logo
Share SHARE
FONT-SIZE Plus   Neg

Proofpoint Expects Pricing IPO In $10-$12/Shr Range - Quick Facts

Proofpoint, Inc. said it estimates pricing the initial public offering of its common stock in a range between $10.00 and $12.00 per share.

The company is selling 5 million shares of common stock and the selling stockholders identified in this prospectus are selling 1.199 million shares of common stock. Proofpoint said it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.

Prior to this offering, there has been no public market for the company's common stock. Proofpoint has applied to list its common stock on the NASDAQ Global Market under the symbol "PFPT."

The underwriters have the option to purchase from the company a maximum of 750 thousand additional shares and from the selling stockholders a maximum of 179,914 additional shares to cover over-allotments of shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Hyundai Motor America, an official NFL sponsor, is returning to Super Bowl advertising, and planning to shoot a documentary as the game is being played to run in its spot. The reigning 2016 USA Today Super Bowl Ad Meter winner, in a statement on Wednesday, said it will film a 90-second documentary during the game that will capture some of the best off-the-field Super Bowl moments. Consumer Financial Protection Bureau or CFPB filed a lawsuit Wednesday against Navient, the nation's largest student loan company, alleging that it failed borrowers at at every stage of repayment. In response, Navient, in a statement, said the allegations are unfounded, and with political motivations, and rejected CFPB ultimatum to settle by Inauguration Day or be sued. Lilly is all set to acquire CoLucid Pharma for $46.50 per share in cash or approximately $960 million.
comments powered by Disqus
Follow RTT